奈力生醫共同創辦人、牟中原院士榮獲由國際介觀結構材料協會理事會（Council of the International Mesostructured Materials Association）頒發的最高榮譽獎項 —「IMMA Award」
IMMA Award 旨在表彰全球在中孔材料的合成、結構設計及應用領域做出宏大且開創性貢獻的傑出學者，是該領域最具代表性的國際學術獎項。
牟中原院士長期深耕中孔材料與奈米材料研究，並在介觀結構材料科學及其應用領域持續作出重要貢獻，其研究成果深刻影響了催化、生物醫藥與材料科學的發展。此次獲獎不僅彰顯牟院士在國際介觀結構材料領域的卓越學術成就，也充分展現其長期研究成果對奈米材料與生醫應用發展的重要影響。
本公司亦深感榮耀，並將持續以牟院士所奠定的奈米材料技術基礎，推動創新奈米藥物遞送技術與生醫應用。
We are proud to announce that our company co-founder, Prof. Chung-Yuan Mou, was officially awarded the 「IMMA Award」, presented by the Council of the International Mesostructured Materials Association
The IMMA Award recognizes outstanding scholars worldwide for their significant and pioneering contributions to the synthesis, structural design, and applications of mesoporous materials. It is one of the most distinguished international academic honors in the field of mesostructured materials.
Prof. Chung-Yuan Mou has devoted his career to the research of mesoporous and nanostructured materials, making sustained and significant contributions to the science and applications of mesostructured materials. His pioneering research has had a profound impact on the advancement of catalysis, nanomedicine, and materials science.
This prestigious recognition highlights Prof. Mou’s outstanding scientific achievements and international influence in the field of mesostructured materials, while underscoring the lasting impact of his research on the development of nanomaterials and biomedical applications.
NTT Biopharma is honored to build upon the nanomaterials technology pioneered by Prof. Mou and to continue advancing innovative nanomedicine and drug delivery technologies for biomedical applications.